Pulmatrix Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Pulmatrix Stock Summary

Pulmatrix competes with Capricor Therapeutics, Akari Therapeutics, Soleno Therapeutics, Bio Path, and Moleculin Biotech. Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts. Pulmatrix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.

Pulmatrix Key Financial Ratios

Pulmatrix Key Balance Sheet Accounts

Pulmatrix Key Cash Accounts

Pulmatrix Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Pulmatrix's current stock value. Our valuation model uses many indicators to compare Pulmatrix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pulmatrix competition to find correlations between indicators driving Pulmatrix's intrinsic value. More Info.Pulmatrix is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Pulmatrix's Return On Equity is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Pulmatrix by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Pulmatrix Systematic Risk

Today, most investors in Pulmatrix Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pulmatrix's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Pulmatrix growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Pulmatrix help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Pulmatrix. We use our internally-developed statistical techniques to arrive at the intrinsic value of Pulmatrix based on widely used predictive technical indicators. In general, we focus on analyzing Pulmatrix Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Pulmatrix's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmatrix. If investors know Pulmatrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmatrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pulmatrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmatrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmatrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.